- Home
- NBIS vs ITGR Comparison
NBIS vs ITGR Comparison
Compare NBIS & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIS
- ITGR
- Stock Information
- Founded
- NBIS 2000
- ITGR 1970
- Country
- NBIS Netherlands
- ITGR United States
- Employees
- NBIS N/A
- ITGR N/A
- Industry
- NBIS
- ITGR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NBIS
- ITGR Health Care
- Exchange
- NBIS NYSE
- ITGR Nasdaq
- Market Cap
- NBIS 4.8B
- ITGR 4.2B
- IPO Year
- NBIS 2011
- ITGR 2000
- Fundamental
- Price
- NBIS $52.58
- ITGR $121.96
- Analyst Decision
- NBIS Strong Buy
- ITGR Strong Buy
- Analyst Count
- NBIS 3
- ITGR 10
- Target Price
- NBIS $52.33
- ITGR $145.90
- AVG Volume (30 Days)
- NBIS 17.1M
- ITGR 392.4K
- Earning Date
- NBIS 07-30-2025
- ITGR 07-24-2025
- Dividend Yield
- NBIS N/A
- ITGR N/A
- EPS Growth
- NBIS N/A
- ITGR N/A
- EPS
- NBIS N/A
- ITGR 2.18
- Revenue
- NBIS $161,400,000.00
- ITGR $1,746,192,000.00
- Revenue This Year
- NBIS $36,445.53
- ITGR $11.03
- Revenue Next Year
- NBIS N/A
- ITGR $7.29
- P/E Ratio
- NBIS N/A
- ITGR $54.91
- Revenue Growth
- NBIS N/A
- ITGR 10.19
- 52 Week Low
- NBIS $14.09
- ITGR $104.93
- 52 Week High
- NBIS $55.04
- ITGR $146.36
- Technical
- Relative Strength Index (RSI)
- NBIS N/A
- ITGR 55.70
- Support Level
- NBIS N/A
- ITGR $119.04
- Resistance Level
- NBIS N/A
- ITGR $121.84
- Average True Range (ATR)
- NBIS 0.00
- ITGR 2.36
- MACD
- NBIS 0.00
- ITGR 0.23
- Stochastic Oscillator
- NBIS 0.00
- ITGR 83.75
About NBIS NEBIUS GROUP N V
Nebius Group NV is a tech company. It is a European provider of infrastructure and services to AI builders globally. The group builds full-stack infrastructure to service the growth of the AI industry, including the scale of GPU clusters, cloud platforms, tools, and services for developers. It has R&D hubs across Europe, North America and Israel.
About ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.